New York State Teachers Retirement System Sells 7,786 Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)

New York State Teachers Retirement System lowered its stake in shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH - Free Report) by 4.4% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 168,672 shares of the medical equipment provider's stock after selling 7,786 shares during the quarter. New York State Teachers Retirement System owned about 0.08% of Zimmer Biomet worth $17,817,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors also recently bought and sold shares of the stock. Dunhill Financial LLC grew its holdings in shares of Zimmer Biomet by 1,090.0% during the 3rd quarter. Dunhill Financial LLC now owns 238 shares of the medical equipment provider's stock worth $26,000 after acquiring an additional 218 shares during the period. Stonebridge Financial Group LLC purchased a new stake in Zimmer Biomet in the fourth quarter worth $25,000. Ashton Thomas Securities LLC bought a new position in Zimmer Biomet in the third quarter worth $28,000. Brooklyn Investment Group bought a new position in Zimmer Biomet in the third quarter worth $35,000. Finally, Kentucky Trust Co purchased a new position in Zimmer Biomet during the 4th quarter valued at about $39,000. 88.89% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

ZBH has been the subject of a number of recent research reports. Needham & Company LLC reiterated a "hold" rating on shares of Zimmer Biomet in a research note on Friday, February 7th. Truist Financial restated a "hold" rating and set a $113.00 price objective (down from $118.00) on shares of Zimmer Biomet in a research note on Monday, February 10th. Raymond James decreased their target price on shares of Zimmer Biomet from $126.00 to $119.00 and set an "outperform" rating for the company in a report on Friday, February 7th. Wells Fargo & Company increased their price target on shares of Zimmer Biomet from $110.00 to $117.00 and gave the company an "equal weight" rating in a report on Thursday, October 31st. Finally, Royal Bank of Canada decreased their price objective on shares of Zimmer Biomet from $130.00 to $125.00 and set an "outperform" rating for the company in a report on Friday, February 7th. Two equities research analysts have rated the stock with a sell rating, eleven have given a hold rating and ten have given a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus target price of $124.15.

Zimmer Biomet Stock Performance

Shares of ZBH traded up $1.13 on Wednesday, reaching $103.31. The company's stock had a trading volume of 2,236,659 shares, compared to its average volume of 1,916,930. Zimmer Biomet Holdings, Inc. has a 12-month low of $97.69 and a 12-month high of $133.90. The stock has a market capitalization of $20.57 billion, a P/E ratio of 23.22, a PEG ratio of 1.89 and a beta of 1.02. The company has a debt-to-equity ratio of 0.43, a current ratio of 1.91 and a quick ratio of 0.99. The stock's 50 day simple moving average is $105.96 and its two-hundred day simple moving average is $107.51.

Zimmer Biomet (NYSE:ZBH - Get Free Report) last issued its quarterly earnings data on Thursday, February 6th. The medical equipment provider reported $2.31 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.30 by $0.01. Zimmer Biomet had a net margin of 11.77% and a return on equity of 12.99%. During the same quarter in the prior year, the business posted $2.20 earnings per share. Research analysts forecast that Zimmer Biomet Holdings, Inc. will post 8.22 earnings per share for the current fiscal year.

Zimmer Biomet Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, January 31st. Stockholders of record on Monday, December 30th were paid a $0.24 dividend. This represents a $0.96 annualized dividend and a dividend yield of 0.93%. The ex-dividend date was Monday, December 30th. Zimmer Biomet's dividend payout ratio (DPR) is currently 21.57%.

About Zimmer Biomet

Zimmer Biomet Holdings, Inc, together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest.